Your Cart ( 2 Items )

• Imiquimod 2.5% and 3.75% for the Treatment of Actinic Keratoses: Two Phase 3,Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies
  February 2014 | Volume 13 | Issue 2 | Original Article | 166 | Copyright © February 2014
  Neil Swanson MD,^a Christina Cognata Smith PharmD,^b Mandeep Kaur MD,^b and Gary Goldenberg MD^c
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Cutaneous Drug Eruptions Induced By Sorafenib: A Case Series
  September 2008 | Volume 7 | Issue 9 | Case Reports | 891 | Copyright © September 2008
  Jessica S. Maddox MD, Elaine F. Kung MD, Vesna Petronic-Rosic MD, Aisha Sethi MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs